XTL Biopharmaceuticals Ltd ADR Financial Flexibility Index
XTL Biopharmaceuticals Ltd ADR financial flexibility index. XTL Biopharmaceuticals Ltd ADR (XTLB) has a Financial Flexibility Index of -10.73x as of December 2022. Free cash flow of $-2.01 Million (operating CF $-2.01 Million minus capex $0.00) represents -11% of total liabilities ($187.00K). See XTLB cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of XTL Biopharmaceuticals Ltd ADR (2003–2025)
Financial flexibility index of XTL Biopharmaceuticals Ltd ADR from 2003 to 2025. Historical Financial Flexibility Index trend for XTL Biopharmaceuticals Ltd ADR across 23 annual periods. Check XTLB cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
XTL Biopharmaceuticals Ltd ADR Financial Flexibility Index by Year (2003–2025)
XTL Biopharmaceuticals Ltd ADR financial flexibility index by year from 2003 to 2025. Year-by-year free cash flow to debt coverage for XTL Biopharmaceuticals Ltd ADR. For the full cash flow conversion analysis, see XTLB operating cash flow.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.44x | $-1.02 Million | $-1.02 Million | $420.00K | ▼ -386.1% |
| 2024 | -0.50x | $-1.56 Million | $-1.62 Million | $3.12 Million | ▲ +85.4% |
| 2023 | -3.43x | $-707.00K | $-707.00K | $206.00K | ▲ +28.8% |
| 2022 | -4.82x | $-901.00K | $-901.00K | $187.00K | ▼ -490.2% |
| 2021 | -0.82x | $-1.05 Million | $-1.05 Million | $1.28 Million | ▲ +75.6% |
| 2020 | -3.34x | $-849.00K | $-850.00K | $254.00K | ▲ +14.4% |
| 2019 | -3.91x | $-906.00K | $-908.00K | $232.00K | ▼ -21.4% |
| 2018 | -3.22x | $-814.00K | $-816.00K | $253.00K | ▼ -750.0% |
| 2017 | -0.38x | $-1.12 Million | $-1.12 Million | $2.97 Million | ▲ +92.5% |
| 2016 | -5.05x | $-1.67 Million | $-1.73 Million | $330.00K | ▼ -22.6% |
| 2015 | -4.12x | $-1.79 Million | $-1.86 Million | $436.00K | ▼ -61.5% |
| 2014 | -2.55x | $-2.46 Million | $-2.47 Million | $965.00K | ▼ -29.8% |
| 2013 | -1.96x | $-2.42 Million | $-2.50 Million | $1.23 Million | ▼ -129.8% |
| 2012 | -0.85x | $-1.42 Million | $-1.51 Million | $1.66 Million | ▲ +70.0% |
| 2011 | -2.84x | $-1.79 Million | $-1.80 Million | $629.00K | ▼ -280.9% |
| 2010 | -0.75x | $-719.00K | $-735.00K | $963.00K | ▲ +78.8% |
| 2009 | -3.51x | $-2.49 Million | $-2.49 Million | $708.00K | ▲ +33.4% |
| 2008 | -5.28x | $-10.58 Million | $-10.58 Million | $2.00 Million | ▼ -37.2% |
| 2007 | -3.85x | $-21.39 Million | $-21.46 Million | $5.56 Million | ▼ -26.7% |
| 2006 | -3.04x | $-12.57 Million | $-12.59 Million | $4.14 Million | ▼ -13.5% |
| 2005 | -2.67x | $-10.43 Million | $-10.47 Million | $3.90 Million | ▼ -12.5% |
| 2004 | -2.38x | $-14.31 Million | $-14.49 Million | $6.02 Million | ▲ +23.8% |
| 2003 | -3.12x | $-13.24 Million | $-13.33 Million | $4.25 Million | — |